May 6, 2020 / 12:14 PM / a month ago

BRIEF-Zai Lab Announces NDA For Omadacycline Granted Priority Review By China’S Nmpa

May 6 (Reuters) - Zai Lab Ltd:

* ZAI LAB ANNOUNCES NDA FOR OMADACYCLINE GRANTED PRIORITY REVIEW BY CHINA’S NMPA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below